ACCESSION: MSBNK-SMB_Measured-HSA001P0185010
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; POSITIVE; Averaged data
DATE: 2025.03.04 (Averaged 2025.02.14, Processed 2025.02.14, Annotated 2025.02.21, Curated 2025.03.04)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Shin-MassBank project in preparation
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MB-POST
COMMENT: DATASET_ID MPST000004
COMMENT: DATASET_TITLE Annotation of various metabolites in SRM 1950 human serum
COMMENT: DATASET_AUTHORS Masatomo Takahashi, Yoshihiro Izumi, Kyushu University
COMMENT: MS1_M/Z_AVERAGED_THRES 0.750
COMMENT: MS2_M/Z_AVERAGED_THRES 4.000
COMMENT: DATASET_FILE_NUM 22
COMMENT: NUM_AVERAGED_SPEC 59
COMMENT: RAW_SPEC {'BLK02_5173': {'bp': 277507.0, 'sum': 643408.0}, '2_posi_4962': {'bp': 217604.0, 'sum': 502402.0}, '7_posi_5003': {'bp': 172721.0, 'sum': 377983.0}, '6_posi_4942': {'bp': 191024.0, 'sum': 426780.0}, '2_posi_5025': {'bp': 193693.0, 'sum': 420349.0}, 'ProcedureBlank_5488': {'bp': 195712.0, 'sum': 427614.0}, '17_posi_4961': {'bp': 195717.0, 'sum': 397681.0}, 'BLK02_4964': {'bp': 231080.0, 'sum': 503192.0}, 'BLK02_5087': {'bp': 245610.0, 'sum': 564199.0}, 'BLK02_5488': {'bp': 272938.0, 'sum': 610466.0}, '5_posi_4922': {'bp': 175422.0, 'sum': 413212.0}, 'ProcedureBlank_5255': {'bp': 182622.0, 'sum': 424793.0}, '18_posi_4922': {'bp': 197529.0, 'sum': 416295.0}, 'BLK02_5235': {'bp': 206529.0, 'sum': 490100.0}, '9_posi_5404': {'bp': 162506.0, 'sum': 418537.0}, '8_posi_4922': {'bp': 167195.0, 'sum': 397737.0}, 'ProcedureBlank_5405': {'bp': 213382.0, 'sum': 497041.0}, '14_posi_4939': {'bp': 231409.0, 'sum': 468131.0}, '8_posi_4983': {'bp': 192273.0, 'sum': 396682.0}, '19_posi_5007': {'bp': 194704.0, 'sum': 432780.0}, '10_posi_4922': {'bp': 194966.0, 'sum': 417964.0}, '13_posi_4922': {'bp': 202695.0, 'sum': 423232.0}, 'ProcedureBlank_4963': {'bp': 215137.0, 'sum': 484291.0}, '16_posi_5046': {'bp': 174694.0, 'sum': 386425.0}, '12_posi_4921': {'bp': 179069.0, 'sum': 423062.0}, '11_posi_4919': {'bp': 179275.0, 'sum': 412705.0}, '1_posi_4984': {'bp': 194889.0, 'sum': 421279.0}, '6_posi_5004': {'bp': 199347.0, 'sum': 429841.0}, '7_posi_4922': {'bp': 201091.0, 'sum': 429641.0}, 'BLK02_5301': {'bp': 226870.0, 'sum': 499296.0}, 'BLK02_5425': {'bp': 232142.0, 'sum': 537382.0}, 'BLK02_5025': {'bp': 238740.0, 'sum': 540401.0}, '5_posi_5403': {'bp': 167666.0, 'sum': 398198.0}, '12_posi_5450': {'bp': 169439.0, 'sum': 373278.0}, '17_posi_5469': {'bp': 185492.0, 'sum': 431488.0}, '2_posi_5426': {'bp': 190251.0, 'sum': 443351.0}, 'ProcedureBlank_5172': {'bp': 211218.0, 'sum': 478413.0}, 'ProcedureBlank_5027': {'bp': 213789.0, 'sum': 502233.0}, '2_posi_5318': {'bp': 218868.0, 'sum': 488592.0}, '3_posi_5493': {'bp': 184109.0, 'sum': 443345.0}, '15_posi_4923': {'bp': 185058.0, 'sum': 388162.0}, '1_posi_5425': {'bp': 187023.0, 'sum': 419022.0}, '4_posi_4985': {'bp': 196166.0, 'sum': 408752.0}, '16_posi_4941': {'bp': 197012.0, 'sum': 406217.0}, '13_posi_5425': {'bp': 198479.0, 'sum': 430322.0}, 'ProcedureBlank_5319': {'bp': 203102.0, 'sum': 442054.0}, 'ProcedureBlank_5088': {'bp': 204155.0, 'sum': 446972.0}, '3_posi_4942': {'bp': 205276.0, 'sum': 462528.0}, '19_posi_4942': {'bp': 217616.0, 'sum': 458890.0}, '3_posi_5004': {'bp': 186322.0, 'sum': 403604.0}, '15_posi_4986': {'bp': 177221.0, 'sum': 386409.0}, 'BLK02_5362': {'bp': 218031.0, 'sum': 505112.0}, '12_posi_4982': {'bp': 190258.0, 'sum': 401331.0}, '9_posi_4691': {'bp': 151491.0, 'sum': 359696.0}, '13_posi_5004': {'bp': 181356.0, 'sum': 391692.0}, '10_posi_4984': {'bp': 182141.0, 'sum': 401639.0}, '18_posi_4984': {'bp': 210712.0, 'sum': 487218.0}, '9_posi_4985': {'bp': 173786.0, 'sum': 397055.0}, '1_posi_5339': {'bp': 168493.0, 'sum': 412021.0}}
COMMENT: RETENTION_TIME_STDEV 0.422
COMMENT: PRECURSOR_M/Z_RAW 185.139389
COMMENT: PRECURSOR_M/Z_STDEV 0.000048
COMMENT: PRECURSOR_IN_MS1 mz 185.139700; int 38.662; delta(ppm) 1.006879
COMMENT: PROPOSED_CHARGE_STATE ND
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_ION_FORM M+H; M+CH3OH+H; mz 217.165973; int 5.247; cor 0.653
COMMENT: PROPOSED_ION_FORM M+H; M+ACN+H; mz 226.166244; int 7.061; cor 0.617
COMMENT: PROPOSED_ION_FORM M+NH4; M+CH3OH+H; mz 200.139380; int 19.755; cor 0.639
COMMENT: PROPOSED_ION_FORM M+Na; M+ACN+Na; mz 226.166244; int 7.061; cor 0.617
COMMENT: PROPOSED_ION_FORM M+ACN+H; M+2ACN+H; mz 226.166244; int 7.061; cor 0.617
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.065; C8H16N4O; [M+H]+; delta(ppm) 0.065170
COMMENT: PROPOSED_MF SevenGoldenRules 0.084; C8H13N3O; [M+NH4]+; delta(ppm) 0.083779
COMMENT: PROPOSED_MF SevenGoldenRules 0.098; C6H13N3O; [M+ACN+H]+; delta(ppm) 0.097830
COMMENT: PROPOSED_MF MS-FINDER 3.434; C8H13N3O; [M+NH4]+; delta(ppm) 0.061608
COMMENT: PROPOSED_MF MS-FINDER 3.268; C6H13N3O; [M+ACN+H]+; delta(ppm) 88313.078931
COMMENT: PROPOSED_MF MS-FINDER 2.808; C8H16N4O; [M+H]+; delta(ppm) 0.061608
COMMENT: PROPOSED_MF SIRIUS5_Sirius 24.442; C8H13N3O; [M+H3N+H]+; delta(ppm) 0.061608
COMMENT: PROPOSED_MF SIRIUS5_Sirius 24.442; C6H13N3O; [M+C2H3N+H]+; delta(ppm) 0.061608
COMMENT: PROPOSED_MF SIRIUS5_Sirius 17.346; C10H18NO2; [M+H]+; delta(ppm) -7.190505
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C6H13N3O; [M+C2H3N+H]+; delta(ppm) 0.061608
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C10H18NO2; [M+H]+; delta(ppm) -7.190505
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C8H13N3O; [M+H3N+H]+; delta(ppm) 0.061608
COMMENT: PROPOSED_MF SIRIUS6_Sirius 45.195; C6H13N3O; [M+C2H3N+H]+; delta(ppm) 0.061608
COMMENT: PROPOSED_MF SIRIUS6_Sirius 45.195; C8H16N4O; [M+H]+; delta(ppm) 0.061608
COMMENT: PROPOSED_MF SIRIUS6_Sirius 45.195; C8H13N3O; [M+H3N+H]+; delta(ppm) 0.061608
COMMENT: PROPOSED_MF SIRIUS6_Sirius 24.099; C4H11N6; [M+C2H3N+H]+; delta(ppm) 7.313826
COMMENT: PROPOSED_MF SIRIUS6_Sirius 24.099; C6H14N7; [M+H]+; delta(ppm) 7.313826
COMMENT: PROPOSED_MF SIRIUS6_Sirius 24.099; C6H11N6; [M+H3N+H]+; delta(ppm) 7.313826
COMMENT: PROPOSED_MF SIRIUS6_Sirius 23.778; C8H20NO2; [M+Na]+; delta(ppm) 51022.828640
COMMENT: PROPOSED_MF SIRIUS6_Sirius 21.270; C5H14FN3O2; [M+H3N+H]+; delta(ppm) -6.110202
COMMENT: PROPOSED_MF SIRIUS6_Sirius 15.272; C3H12FN6O; [M+H3N+H]+; delta(ppm) 1.141927
COMMENT: PROPOSED_MF SIRIUS6_Sirius 15.125; C8H15O2; [M+C2H3N+H]+; delta(ppm) -7.190505
COMMENT: PROPOSED_MF SIRIUS6_Sirius 15.125; C10H18NO2; [M+H]+; delta(ppm) -7.190505
COMMENT: PROPOSED_MF SIRIUS6_Sirius 15.125; C10H15O2; [M+H3N+H]+; delta(ppm) -7.190505
COMMENT: PROPOSED_MF SIRIUS6_Sirius 4.735; C8H14F3; [M+H3N+H]+; delta(ppm) 6.017214
COMMENT: PROPOSED_MF SIRIUS6_Sirius -0.607; C4H16N4OP; [M+H3N+H]+; delta(ppm) -1.607956
COMMENT: PROPOSED_MF SIRIUS6_Sirius -6.733; C2H14N7P; [M+H3N+H]+; delta(ppm) 5.644238
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C8H20NO2; [M+Na]+; delta(ppm) 51022.828640
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C6H13N3O; [M+C2H3N+H]+; delta(ppm) 0.061608
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C8H16N4O; [M+H]+; delta(ppm) 0.061608
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C8H13N3O; [M+H3N+H]+; delta(ppm) 0.061608
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.488; MUEHLDAHWSCFAG-UHFFFAOYSA-N; [M+NH4]+; 2-(dimethylamino)-5,6-dimethylpyrimidin-4-ol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.460; LISUGPHHMMHOHJ-UHFFFAOYSA-N; [M+NH4]+; Solsodomine B
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.402; ZEIPMWRDENQLAY-UHFFFAOYSA-N; [M+NH4]+; 5-(4-piperidinyl)-1,2-dihydropyrazol-3-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.323; KFCMMJDSUVSXAJ-UHFFFAOYSA-N; [M+NH4]+; 3-[(2-cyanoethyl)(2-hydroxyethyl)amino]propanenitrile
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.125; YEVAUEKXKYEZAL-GORDUTHDSA-N; [M+ACN+H]+; UNPD170723
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.029; SKJJGBRWKOFYAD-UHFFFAOYSA-N; [M+ACN+H]+; piperidin-1-ylurea
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.986; VNRJGEMERJZKLQ-UHFFFAOYSA-N; [M+ACN+H]+; 2-piperazin-1-ylacetamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; MUEHLDAHWSCFAG-UHFFFAOYSA-N; [M+NH4]+; 2-(dimethylamino)-5,6-dimethylpyrimidin-4-ol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; VNRJGEMERJZKLQ-UHFFFAOYSA-N; [M+ACN+H]+; 2-piperazin-1-ylacetamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.929; YEVAUEKXKYEZAL-GORDUTHDSA-N; [M+ACN+H]+; UNPD170723
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.836; KFCMMJDSUVSXAJ-UHFFFAOYSA-N; [M+NH4]+; 3-[(2-cyanoethyl)(2-hydroxyethyl)amino]propanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.774; ZEIPMWRDENQLAY-UHFFFAOYSA-N; [M+NH4]+; 5-(4-piperidinyl)-1,2-dihydropyrazol-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.766; SKJJGBRWKOFYAD-UHFFFAOYSA-N; [M+ACN+H]+; piperidin-1-ylurea
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.723; LISUGPHHMMHOHJ-UHFFFAOYSA-N; [M+NH4]+; Solsodomine B
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.721; FYJORSKXVAOJFZ-UHFFFAOYSA-N; [M+ACN+H]+; 4-methylpiperazine-1-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.759; VNRJGEMERJZKLQ-UHFFFAOYSA-N; [M+ACN+H]+; 2-piperazin-1-ylacetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.277; HPYONZVIPMACEZ-UHFFFAOYSA-N; [M+ACN+H]+; N-methylpiperazine-1-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.259; KCDIWATZOVCVKI-UHFFFAOYSA-N; [M+ACN+H]+; piperidin-4-ylurea
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.192; AHZIDBXGSJQKLX-UHFFFAOYSA-N; [M+ACN+H]+; 4-aminopiperidine-1-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.138; MUEHLDAHWSCFAG-UHFFFAOYSA-N; [M+NH4]+; 2-(dimethylamino)-4,5-dimethyl-1H-pyrimidin-6-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.115; TZNAROISIPROOZ-UHFFFAOYSA-N; [M+ACN+H]+; 1-(3-aminopropyl)imidazolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.056; GPEIVMXHSLWCPA-UHFFFAOYSA-N; [M+ACN+H]+; 4-aminopiperidine-4-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.952; FMWWRALTYIWZEB-UHFFFAOYSA-N; [M+NH4]+; 3,3-dimethyl-1-(1,2,4-triazol-1-yl)butan-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.934; LAPGYTBMWPMHJR-YFKPBYRVSA-N; [M+ACN+H]+; (3S)-3-amino-N-methylpyrrolidine-1-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.934; FLAITKOPRGFZIF-UHFFFAOYSA-N; [M+ACN+H]+; 3-aminopiperidine-3-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.919; GZZNBQLBGSVOOZ-UHFFFAOYSA-N; [M+NH4]+; 1-(oxan-4-yl)pyrazol-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.918; NFZYPUZESMHUFD-UHFFFAOYSA-N; [M+ACN+H]+; pyrrolidin-2-ylmethylurea
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.908; ZKZFDOOBJYSKFU-UHFFFAOYSA-N; [M+ACN+H]+; 3-(aminomethyl)pyrrolidine-1-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.859; ZEIPMWRDENQLAY-UHFFFAOYSA-N; [M+NH4]+; 5-piperidin-4-yl-1,2-dihydropyrazol-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.855; JPNSPJDRFUHSRZ-UHFFFAOYSA-N; [M+ACN+H]+; 2-pyrrolidin-1-ylacetohydrazide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.823; NUIMBFDFBVDYGA-UHFFFAOYSA-N; [M+ACN+H]+; 4-hydroxypiperidine-1-carboximidamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.795; WDKQNCOJYGKYPL-UHFFFAOYSA-N; [M+ACN+H]+; N'-hydroxypiperidine-1-carboximidamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.788; QDYWEAYMBBJBPO-UHFFFAOYSA-N; [M+ACN+H]+; 1,4-diazepane-1-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.787; BUQMXMDRGBXRCA-UHFFFAOYSA-N; [M+ACN+H]+; 1-amino-3-cyclopentylurea
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.783; HICOHQNXBHNIFZ-UHFFFAOYSA-N; [M+ACN+H]+; 2-amino-1-piperazin-1-ylethanone
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.772; SOENJDNFPOBWLW-UHFFFAOYSA-N; [M+ACN+H]+; 3-(dimethylamino)azetidine-3-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.751; WGWMISVGGQSKQM-UHFFFAOYSA-N; [M+ACN+H]+; piperidin-3-ylurea
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.742; MBARKXJKNRDGRA-KDQPPDNESA-N; [M+ACN+H]+; (2E)-N'-ethyl-2-hydroxyimino-N,N-dimethylethanimidamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.720; AETYEPQFHBJEFI-UHFFFAOYSA-N; [M+ACN+H]+; 1-methyl-3-pyrrolidin-3-ylurea
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.717; JLQKHGQBZVLLOZ-UHFFFAOYSA-N; [M+ACN+H]+; pyrrolidin-3-ylmethylurea
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.699; ADYHKWHEJHSAGO-UHFFFAOYSA-N; [M+ACN+H]+; 4-methylmorpholine-2-carboximidamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.692; STWYOHYJSCZMRP-UHFFFAOYSA-N; [M+ACN+H]+; 3-(methylamino)pyrrolidine-1-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.580; AERHQVIADZNUCA-UHFFFAOYSA-N; [M+ACN+H]+; 2-(oxan-4-yl)guanidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.578; ZOGISVNCCRKCKA-UHFFFAOYSA-N; [M+ACN+H]+; 2-morpholin-4-ylethanimidamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.549; CEJHJCGBNCIXGF-UHFFFAOYSA-N; [M+ACN+H]+; N'-hydroxy-2-pyrrolidin-1-ylethanimidamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.287; CWZUYOLYTOIBRY-UHFFFAOYSA-N; [M+ACN+H]+; 1-ethyl-4-nitrosopiperazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.250; BJQUSXNOSUWNPN-UHFFFAOYSA-N; [M+NH4]+; 4-amino-2-methyl-5-propyl-1H-pyrimidin-6-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.230; AYIYPOXMXHVYQC-UHFFFAOYSA-N; [M+NH4]+; 4-amino-5-butyl-1H-pyrimidin-6-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.208; MPYNENJKQSNBDF-UHFFFAOYSA-N; [M+NH4]+; 3-methyl-5-piperidin-3-yl-1,2,4-oxadiazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.200; ILBZSWSRACAXTH-UHFFFAOYSA-N; [M+NH4]+; 2-[(4,6-dimethylpyrimidin-2-yl)amino]ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.136; XHAHWJKEJRHFHD-UHFFFAOYSA-N; [M+NH4]+; 2-[(6-aminopyridin-3-yl)-methylamino]ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.134; ZYKUMBAVXKKVKL-UHFFFAOYSA-N; [M+NH4]+; 3-piperidin-4-yl-1H-imidazol-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.092; KDYGKJXNUZDJJP-XLPZGREQSA-N; [M+NH4]+; (1R,2R,3S)-3-amino-2-(4-methylpyrazol-1-yl)cyclobutan-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.056; XPQGGJHFUOMKTM-UHFFFAOYSA-N; [M+NH4]+; 4-N-(2-methoxyethyl)pyridine-3,4-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.050; ZEOLFPULWLFLOJ-UHFFFAOYSA-N; [M+NH4]+; 6-methoxy-2-N,2-N-dimethylpyridine-2,5-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.031; CNYQWRSPRSMVCG-UHFFFAOYSA-N; [M+NH4]+; 3-methyl-5-piperidin-4-yl-1,2,4-oxadiazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.028; KYRHMGHAXQVVIQ-UHFFFAOYSA-N; [M+NH4]+; N-(2-aminoethyl)-1-methylpyrrole-2-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.016; NAKGVVXLLRPXJL-RITPCOANSA-N; [M+NH4]+; (5R,7S)-5,7-dimethyl-4,5,6,7-tetrahydro-1H-pyrazolo[1,5-a]pyrimidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.011; OMXZUACVERIOMC-UHFFFAOYSA-N; [M+NH4]+; 5,6,7,8-tetrahydro-4H-pyrazolo[1,5-a][1,4]diazepin-2-ylmethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.010; NVOWYHFTPBVXPW-UHFFFAOYSA-N; [M+NH4]+; 2-(6,8-dihydro-5H-imidazo[2,1-c][1,4]oxazin-3-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.007; XXGJXWZYCCJXKI-UHFFFAOYSA-N; [M+NH4]+; (1-methyl-4,5,6,7-tetrahydropyrazolo[4,3-c]pyridin-3-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.007; YUDISKHKDSDHIP-UHFFFAOYSA-N; [M+NH4]+; 2-[4-(methoxymethyl)pyrimidin-2-yl]ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.985; BMJCMEAWGNCZOF-UHFFFAOYSA-N; [M+NH4]+; 2-amino-3-(5-methylpyrimidin-2-yl)propan-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.985; JQSGNNVZAVLVHV-UHFFFAOYSA-N; [M+NH4]+; 2-(1,3,5-trimethylpyrazol-4-yl)acetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.979; OIAVMMWQABGRMB-UHFFFAOYSA-N; [M+NH4]+; 1-(1,3-oxazol-2-yl)piperidin-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.976; YOCZIQYIDLPSNP-UHFFFAOYSA-N; [M+NH4]+; 2-(5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridin-3-yl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.966; DAHJAGXLQQWAHD-UHFFFAOYSA-N; [M+NH4]+; (1-methyl-6,7-dihydro-4H-pyrano[4,3-c]pyrazol-3-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.960; CGVQGJNXJICZAD-UHFFFAOYSA-N; [M+NH4]+; (1-cyclopentyltriazol-4-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.955; PMIXFOJXQSPVTD-UHFFFAOYSA-N; [M+NH4]+; 3-(2-methylpyrazol-3-yl)pyrrolidin-3-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.955; VCHJIYGWBCJHGW-UHFFFAOYSA-N; [M+NH4]+; 5-methyl-1-(oxolan-3-yl)pyrazol-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.952; KDCVAJDCQDCSPQ-UHFFFAOYSA-N; [M+NH4]+; 4-(1,2,4-oxadiazol-5-yl)cyclohexan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.951; NEHQWJALQCSBBX-UHFFFAOYSA-N; [M+NH4]+; 2-methyl-5-piperidin-4-yl-1,3,4-oxadiazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.941; KMBYPOQMHIVTQY-UHFFFAOYSA-N; [M+NH4]+; (5-propan-2-yloxypyrazin-2-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.937; JWHDQIBDWOXMLS-SFYZADRCSA-N; [M+NH4]+; (2S,3R)-2-(1-methylpyrazol-4-yl)oxolan-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.933; YLFNQHRIQYXGRF-RNFRBKRXSA-N; [M+NH4]+; (2R,3R)-2-(1-methylimidazol-2-yl)oxolan-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.910; KCXASWIJXRCXDP-UHFFFAOYSA-N; [M+NH4]+; 2-methyl-5-(oxolan-2-yl)pyrazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.908; SMSZXJUIBZVLLN-JXMROGBWSA-N; [M+NH4]+; (NE)-N-[1-(3,5-dimethylpyrazol-1-yl)propan-2-ylidene]hydroxylamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.874; AKTFDUGMLOBQFF-SFYZADRCSA-N; [M+NH4]+; (1R,2S)-2-(1H-pyrazol-4-yloxy)cyclopentan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.872; KPJOXDBKXBMZPL-UHFFFAOYSA-N; [M+NH4]+; 5-cyclohexyl-1,3,4-oxadiazol-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.869; KOHANRWITFLUEL-UHFFFAOYSA-N; [M+NH4]+; 6-(2-methylpropoxy)pyrimidin-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.869; QBSZYNLEJXKKCN-UHFFFAOYSA-N; [M+NH4]+; 7,7-dimethyl-3a,4,5,6-tetrahydro-2H-pyrazolo[3,4-c]pyridin-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.864; DJWSZBRFBMIGIW-UHFFFAOYSA-N; [M+NH4]+; 3-(4-methylpiperazin-1-yl)-3-oxopropanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.860; VTMGMNUDLLSXDI-UHFFFAOYSA-N; [M+NH4]+; [5-(1H-pyrazol-5-yl)oxolan-2-yl]methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.835; AQPGNHFZFXIMJB-UHFFFAOYSA-N; [M+NH4]+; 5-(oxan-4-yl)-1H-pyrazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.833; WFVIVFUPBWZTNO-UHFFFAOYSA-N; [M+NH4]+; 1-(oxan-2-yl)pyrazol-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.827; PZKAJXOKSGTLNG-UHFFFAOYSA-N; [M+NH4]+; 1-(oxolan-3-ylmethyl)pyrazol-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.812; ZCYLUQUNKIIGEI-UHFFFAOYSA-N; [M+NH4]+; 2-butoxypyrimidin-5-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.806; ZIBMLRNNEACWHX-UHFFFAOYSA-N; [M+NH4]+; 3-methyl-5-piperidin-2-yl-1,2,4-oxadiazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.801; OXKCHLGFMPFNMY-UHFFFAOYSA-N; [M+NH4]+; 1-(oxolan-2-ylmethyl)pyrazol-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.797; DLHGRFWTUBXSRO-UHFFFAOYSA-N; [M+NH4]+; 5,6,6-trimethyl-2,4-dihydro-1H-pyrrolo[3,4-c]pyrazol-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.787; KEYFHYRXUHGMLW-UHFFFAOYSA-N; [M+NH4]+; 5-(ethoxymethyl)-2-methylpyrimidin-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.784; ARRIZRNPHNCKOQ-UHFFFAOYSA-N; [M+NH4]+; 5-methyl-3-piperidin-4-yl-1,2,4-oxadiazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.775; KSBIDPYAPFHSRG-UHFFFAOYSA-N; [M+NH4]+; 2-(1-methylpyrazol-4-yl)morpholine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.762; LWBBFLJNOWLMTE-UHFFFAOYSA-N; [M+NH4]+; 2-(pyrazol-1-ylmethyl)morpholine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.743; IHUUUXDJWBUGQS-UHFFFAOYSA-N; [M+NH4]+; 2-(2-methylpyrazol-3-yl)morpholine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.740; PAFUQVUJVMLGAV-UHFFFAOYSA-N; [M+NH4]+; 3-(2-methylpyrazol-3-yl)morpholine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.739; ZJPXISVPGQJGIN-UHFFFAOYSA-N; [M+NH4]+; 3-(1-methylpyrazol-4-yl)morpholine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.737; SINGMNYTTDSEPO-UHFFFAOYSA-N; [M+NH4]+; 1-(oxan-4-yl)pyrazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.731; VOQHIEDNNJKFMY-UHFFFAOYSA-N; [M+NH4]+; 4-(1H-pyrazol-5-yl)piperidin-4-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.724; ULUVRBKBIJMHJF-UHFFFAOYSA-N; [M+NH4]+; 2-(oxolan-3-ylmethyl)pyrazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.723; ISPKAKJVQQMQMU-RQJHMYQMSA-N; [M+NH4]+; 2-[(2S,4R)-4-methoxypyrrolidin-2-yl]-1H-imidazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.705; SFCHBJCTQQMHET-UHFFFAOYSA-N; [M+NH4]+; 5-(cyclopentylmethyl)-1,3,4-oxadiazol-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.701; RNZPWGXBWMZDBW-UHFFFAOYSA-N; [M+NH4]+; 5-methyl-3-piperidin-3-yl-1,2,4-oxadiazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.682; LHEQKPKPNWUCNA-UHFFFAOYSA-N; [M+NH4]+; 1-(oxan-3-yl)pyrazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.678; WBWODELEHXFUBD-UHFFFAOYSA-N; [M+NH4]+; 1-(5-methyl-1,2,4-oxadiazol-3-yl)cyclopentan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.667; JBBBRIUESLSJTN-UHFFFAOYSA-N; [M+NH4]+; 2-(1-methylimidazol-4-yl)morpholine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.658; UNSDDPKYYYBZPH-UHFFFAOYSA-N; [M+NH4]+; 1-(oxolan-3-ylmethyl)pyrazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.618; GGDFRBSJVQPWHX-UHFFFAOYSA-N; [M+NH4]+; 5,6-dimethyl-3-propan-2-yloxy-1,2,4-triazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.614; OKBYMHXCUZZFMU-UHFFFAOYSA-N; [M+NH4]+; 5-methyl-3-piperidin-2-yl-1,2,4-oxadiazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.550; VJMTXOUUYNPWLF-UHFFFAOYSA-N; [M+NH4]+; 3-(piperazin-1-ylmethyl)-1,2-oxazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.530; PARYBDOLVNBMAW-UHFFFAOYSA-N; [M+NH4]+; 3-(azepan-2-yl)-1,2,4-oxadiazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.521; QIWFSCBVELQMSW-UHFFFAOYSA-N; [M+NH4]+; 5-tert-butyl-3-methoxy-1,2,4-triazine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -103.878; QDYWEAYMBBJBPO; [M+C2H3N+H]+; 1,4-diazepane-1-carboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -118.952; AETYEPQFHBJEFI; [M+C2H3N+H]+; Urea, N-methyl-N''-3-pyrrolidinyl-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -124.460; DOKOLURCKPWOMU; [M+C2H3N+H]+; 5-propyl-1,3,5-triazinan-2-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -158.774; LRRXQOLSXNHYGG; [M+C2H3N+H]+; Nitroso-3,5-dimethylpiperazine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -181.643; WDKQNCOJYGKYPL; [M+C2H3N+H]+; N-(N-Hydroxyamidino)piperidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -221.016; YEVAUEKXKYEZAL; [M+C2H3N+H]+; 2-[(Z)-4-hydroxy-3-methylbut-2-enyl]guanidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -232.149; KFCMMJDSUVSXAJ; [M+H3N+H]+; 3,3''-[(2-hydroxyethyl)imino]dipropanenitrile
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -234.060; MUEHLDAHWSCFAG; [M+H3N+H]+; 2-Dimethylamino-5,6-dimethylpyrimidin-4-ol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -238.274; QIWFSCBVELQMSW; [M+H3N+H]+; 5-tert-Butyl-3-methoxy-as-triazine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -240.160; BJQUSXNOSUWNPN; [M+H3N+H]+; 6-Amino-2-methyl-5-propyl-4-pyrimidinol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -243.479; GGDFRBSJVQPWHX; [M+H3N+H]+; 5,6-Dimethyl-3-isopropoxy-as-triazine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -250.010; ZEIPMWRDENQLAY; [M+H3N+H]+; 5-piperidin-4-yl-1H-pyrazol-3-ol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -250.168; NEHQWJALQCSBBX; [M+H3N+H]+; 2-methyl-5-piperidin-4-yl-1,3,4-oxadiazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -256.621; VRQZHEGMFMTVGK; [M+H3N+H]+; 1,5,N(4),N(4)-Tetramethylcytosine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -260.288; FMWWRALTYIWZEB; [M+H3N+H]+; ACMC-20cjlb
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -271.735; GGTLWUZUPFXLAI; [M+H3N+H]+; 2-Ethyl-5-(methoxymethyl)pyrimidin-4-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -278.599; UVBNRAJQMQGVPO; [M+H]+; 2-Spirocyclohexane doxyl
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -284.813; KEYFHYRXUHGMLW; [M+H3N+H]+; Oprea1_408005
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -310.216; AYIYPOXMXHVYQC; [M+H3N+H]+; 6-Amino-5-butyl-4-pyrimidinol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -313.597; LISUGPHHMMHOHJ; [M+H3N+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -316.448; KSBIDPYAPFHSRG; [M+H3N+H]+; 2-(1-methyl-1H-pyrazol-4-yl)morpholine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -329.235; PLEUJIDJQYIEKB; [M+H3N+H]+; Oprea1_361160
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -346.579; ZCYLUQUNKIIGEI; [M+H3N+H]+; 2-butoxypyrimidin-5-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -350.128; YOCZIQYIDLPSNP; [M+H3N+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -352.960; WFVIVFUPBWZTNO; [M+H3N+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -369.960; AQPGNHFZFXIMJB; [M+H3N+H]+; 5-(oxan-4-yl)-1H-pyrazol-3-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -380.549; KCXASWIJXRCXDP; [M+H3N+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.176; QDYWEAYMBBJBPO; [M+C2H3N+H]+; 1,4-diazepane-1-carboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.147; KFCMMJDSUVSXAJ; [M+H3N+H]+; 3,3''-[(2-hydroxyethyl)imino]dipropanenitrile
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.065; UVBNRAJQMQGVPO; [M+H]+; 2-Spirocyclohexane doxyl
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -113.064; VNRJGEMERJZKLQ; [M+C2H3N+H]+; 2-Piperazin-1-ium-1-ylacetamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -127.251; YEVAUEKXKYEZAL; [M+C2H3N+H]+; N-(4-hydroxy-3-methylbut-2-en-1-yl)guanidine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -144.708; CWZUYOLYTOIBRY; [M+C2H3N+H]+; 1-Ethyl-4-nitroso-piperazine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -156.474; MBARKXJKNRDGRA; [M+C2H3N+H]+; N,N-Dimethyl-N'-ethyl-2-(hydroxyimino)acetamidine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -156.740; HPYONZVIPMACEZ; [M+C2H3N+H]+; N-methylpiperazine-1-carboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -164.548; LRRXQOLSXNHYGG; [M+C2H3N+H]+; 1-Nitroso-3,5-dimethylpiperazine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -165.022; QDYWEAYMBBJBPO; [M+C2H3N+H]+; 1,4-Diazepane-1-carboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -173.763; FYJORSKXVAOJFZ; [M+C2H3N+H]+; 4-Methylpiperazin-4-ium-1-carboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -188.766; WDKQNCOJYGKYPL; [M+C2H3N+H]+; Hydroxycarbamimidoyl-piperidine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -192.520; DOKOLURCKPWOMU; [M+C2H3N+H]+; Tetrahydro-5-propyl-1,3,5-triazin-2(1H)-one
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -199.728; KFCMMJDSUVSXAJ; [M+H3N+H]+; 3-[(2-cyanoethyl)(2-hydroxyethyl)amino]propanenitrile
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -282.145; PAFUQVUJVMLGAV; [M+H3N+H]+; (3R)-3-(2-methylpyrazol-3-yl)morpholine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -284.266; YUDISKHKDSDHIP; [M+H3N+H]+; 2-[4-(Methoxymethyl)pyrimidin-2-yl]ethanamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -288.320; JQSGNNVZAVLVHV; [M+H3N+H]+; 2-(1,3,5-trimethyl-1H-pyrazol-4-yl)acetamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -300.197; FMWWRALTYIWZEB; [M+H3N+H]+; 3,3-Dimethyl-1-(1H-1,2,4-triazol-1-yl)butan-2-one
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -302.550; UUECYTLJOJGWJK; [M+H3N+H]+; 1�??isopropyl�??3,5�??dimethyl�??4�??nitrosopyrazole (Substrate 9)
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -302.631; YOCZIQYIDLPSNP; [M+H3N+H]+; 2-{5H,6H,7H,8H-[1,2,4]triazolo[4,3-a]pyridin-3-yl}ethan-1-ol
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -308.596; GGDFRBSJVQPWHX; [M+H3N+H]+; as-Triazine, 5,6-dimethyl-3-isopropoxy-
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -310.560; QIWFSCBVELQMSW; [M+H3N+H]+; 1,2,4-Triazine, 5-(1,1-dimethylethyl)-3-methoxy-
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -310.604; VJMTXOUUYNPWLF; [M+H3N+H]+; 1-(1,2-Oxazol-3-ylmethyl)piperazine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -323.628; XOBKWTGIEURIQD; [M+H]+; 1,7,9-Trimethyl-2,3,4,5,8,9-hexahydropurin-9-ium-6-one
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.215; VNRJGEMERJZKLQ; [M+C2H3N+H]+; 2-Piperazin-1-ium-1-ylacetamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.141; KFCMMJDSUVSXAJ; [M+H3N+H]+; 3-[(2-cyanoethyl)(2-hydroxyethyl)amino]propanenitrile
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.063; XOBKWTGIEURIQD; [M+H]+; 1,7,9-Trimethyl-2,3,4,5,8,9-hexahydropurin-9-ium-6-one
COMMENT: CONFIDENCE Level 5: Exact mass of interest 185.139699; Observed in MS1; Charge state Unknown;
CH$NAME: Uncharacterized
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Serum
AC$INSTRUMENT: Nexera X2 UHPLC system, Shimadzu - Q Exactive Orbitrap, Thermo Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 20 V
AC$MASS_SPECTROMETRY: COLLISION_GAS N2
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 0.75; MS2(ppm) 4.00
AC$CHROMATOGRAPHY: COLUMN_NAME GL-HilicAex 2.1 x 150 mm, 5 mm (Resonac)
AC$CHROMATOGRAPHY: FLOW_GRADIENT B conc(%). 0 min: 95, 0.5 min: 95, 15.5 min: 40, 16.5 min: 0, 26.5 min: 0, 27.5 min: 95, 35 min: 95.
AC$CHROMATOGRAPHY: FLOW_RATE 0.4 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 10.241
MS$FOCUSED_ION: PRECURSOR_M/Z 185.139699
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-000i-1900000000-a5f4a0a37abb03f13f67
PK$ANNOTATION: m/z int annotation m/z_nocal m/z_std(ppm) int_std cor n
  71.0602568 61.9125 ? 71.060870 1.2102 12.74 0.4241 59
  72.0443035 68.2048 ? 72.044910 1.0133 11.96 0.3492 59
  85.0759458 41.7241 ? 85.076425 1.2930 9.31 0.3321 58
  87.0915769 36.9626 ? 87.092030 1.5731 7.92 0.4200 58
  97.0759650 30.6816 ? 97.076310 1.7203 7.81 0.1748 53
  114.1025482 69.3156 ? 114.102730 1.1656 10.89 0.5003 59
  115.0866096 219.1606 ? 115.086780 0.6778 20.18 0.8275 59
  125.0709086 32.2461 ? 125.070950 1.9669 7.73 0.2146 57
  129.0658866 36.4577 ? 129.065870 1.9602 11.45 0.2848 53
  142.0975071 39.7873 ? 142.097410 2.0479 8.31 0.4611 59
  167.1292132 81.6108 ? 167.129100 1.5377 12.98 0.5873 59
  168.1131538 62.8667 ? 168.113040 1.5585 11.47 0.3967 59
  185.0914096 107.8530 ? 185.091285 3.0796 28.69 0.3887 58
  185.1398346 999.0000 ? 185.139710 0.3835 0.00 1.0000 59
PK$NUM_PEAK: 14
PK$PEAK: m/z int. rel.int.
  71.060257 61.91 61
  72.044303 68.20 68
  85.075946 41.72 41
  87.091577 36.96 36
  97.075965 30.68 30
  114.102548 69.32 69
  115.086610 219.16 219
  125.070909 32.25 32
  129.065887 36.46 36
  142.097507 39.79 39
  167.129213 81.61 81
  168.113154 62.87 62
  185.091410 107.85 107
  185.139835 999.00 999
//
